Company profile
Wildflower Brands Inc.
OTC: WLDFF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#697 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 24
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), Piotroski F · ↓ market scale, disclosure history
Methodology →Revenue TTM
$14.5M
Rev growth YoY (TTM)
+318.7%
Net income (FY)
-$3.7M
Employees
7
as of 2026-08-31
Market cap
$1.4k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.4M7.1M CAD2019
Net income-$3.7M-5.0M CAD2019
Operating income-$1.8M-2.4M CAD2019
Total assets$45.7M59.8M CAD2019
Liabilities$9.7M12.7M CAD2019
Equity$36.0M47.0M CAD2019
Revenue trend
FY2017 – FY2019 · USD
FY17
FY18
FY19
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Wildflower Brands Inc.’s revenue?
Wildflower Brands Inc. booked $5.4M in FY2019 revenue, growing 383% year over year — faster than 93% of Healthcare companies we track, at a -69.9% net margin.
Peers · Healthcare
CarePayment Technologies, Inc.——Tristar Wellness Solutions Inc.——WellQuest Medical & Wellness Corporation——Biomerica, Inc.47DTargeted Medical Pharma, Inc.——Plus Therapeutics, Inc.30DKey facts
CEOStephen W. Pearce
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: WLDFF
Employees7
IPO date2017-01-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.